SINOVAC BIOTECH LTD Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price
SINOVAC BIOTECH LTD (SVA) had Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price of $4.98 per share as of 2022-12-31, per its 20-F filed 2023-05-01.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 · last filed 2023-05-01
- 2022-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $4.98.
- 2021-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $4.98.
- 2020-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $4.98.
- 2019-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $4.98.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2022-12-31 | $4.98 20-F · filed 2023-05-01 |
| 2021-12-31 | $4.98 20-F · filed 2022-04-29 |
| 2020-12-31 | $4.98 20-F · filed 2021-04-22 |
| 2019-12-31 | $4.98 20-F · filed 2020-04-30 |
| 2018-12-31 | $4.98 20-F · filed 2019-04-29 |
| 2017-12-31 | $4.98 20-F · filed 2018-05-11 |
| 2016-12-31 | $4.83 20-F · filed 2017-11-22 |
| 2015-12-31 | $2.37 20-F · filed 2016-04-25 |
| 2014-12-31 | $2.06 20-F · filed 2015-04-29 |
| 2013-12-31 | $1.96 20-F · filed 2014-04-16 |
| 2012-12-31 | $1.68 20-F/A · filed 2013-05-23 |